Tag: Hatch-Waxman Act

First-Mover Advantage: How Generic Drug Manufacturers Secure Long-Term Market Dominance

First-mover advantage in generic pharmaceuticals lets the first company to market a generic drug capture up to 90% of the market. The Hatch-Waxman Act creates a 180-day exclusivity period, but benefits extend years later due to pharmacy stocking habits and patient loyalty. Data shows domestic manufacturers gain 22% higher market saturation. However, Authorized Generics and pay-for-delay deals can erode this advantage. Learn how factors like drug type and company size influence long-term success.